Share on StockTwits

Allscripts Healthcare Solutions (NASDAQ:MDRX)‘s stock had its “outperform” rating reaffirmed by Raymond James in a research note issued on Friday. They currently have a $18.00 price target on the stock, down from their previous price target of $18.50. Raymond James’ price target indicates a potential upside of 19.76% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, July 23rd. They now have a $21.00 price target on the stock, up previously from $15.00. Separately, analysts at ISI Group upgraded shares of Allscripts Healthcare Solutions from a “buy” rating to a “strong-buy” rating in a research note on Thursday, July 10th. They now have a $19.00 price target on the stock, up previously from $17.50. They noted that the move was a valuation call. Finally, analysts at Topeka Capital Markets initiated coverage on shares of Allscripts Healthcare Solutions in a research note on Friday, June 27th. They set a “hold” rating and a $16.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $18.67.

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 15.03 on Friday. Allscripts Healthcare Solutions has a one year low of $13.72 and a one year high of $19.68. The stock’s 50-day moving average is $16.01 and its 200-day moving average is $16.43. The company’s market cap is $2.702 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09. The company had revenue of $351.30 million for the quarter, compared to the consensus estimate of $353.12 million. During the same quarter in the previous year, the company posted $0.13 earnings per share. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, analysts predict that Allscripts Healthcare Solutions will post $0.38 earnings per share for the current fiscal year.

Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.